Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3057201000168119 | Strensiq (asfotase alfa 40 mg / 1 mL) injection, 1 x 1 mL vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3057211000168116 | Strensiq 40 mg/mL injection, 1 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Strensiq 40 mg/mL injection, 1 mL vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Strensiq 40 mg/mL injection, 1 mL vial | Is a | Strensiq 40 mg/mL injection, 1 mL vial | true | Inferred relationship | Some | ||
| Strensiq 40 mg/mL injection, 1 mL vial | has TPUU | Strensiq 40 mg/mL injection, vial | true | Inferred relationship | Some | 1 | |
| Strensiq 40 mg/mL injection, 1 mL vial | has container type | vial | true | Inferred relationship | Some | ||
| Strensiq 40 mg/mL injection, 1 mL vial | has TP | Strensiq | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR